Patents Issued in January 15, 2008
  • Patent number: 7319009
    Abstract: The present invention makes available rapid, effective assays for screening and identifying pharmaceutically effective compounds that specifically interact with and modulate the activity of a cellular receptor or ion channel. The subject assays enable rapid screening of large numbers of polypeptides in a library to identify those polypeptides which induce or antagonize receptor bioactivity. The subject assays are particularly amenable for identifying agonists and antagonists for orphan receptors. In particular the present invention makes available novel ligand agonists of human formyl peptide receptor like-1 (FPRL-1) receptors. These novel ligand agonists are used in the assays of the invention to identify modulators of FPRL-1 receptor.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: January 15, 2008
    Assignee: Cadus Technologies, Inc.
    Inventors: Christine A. Klein, Andrew J. Murphy, Jeremy Paul
  • Patent number: 7319010
    Abstract: The present invention relates to compositions and methods for cancer therapies and diagnostics, including but not limited to, cancer markers. In particular, the present invention provides tumor antigens associated with specific cancers and diagnostic assays for the detection of such antigens and associated autoantibodies as indicative of the presence of specific cancers. The present invention further provides cancer immunotherapy utilizing the tumor antigens of the present invention.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: January 15, 2008
    Assignee: The Regents of the University of Michigan
    Inventors: Myeong Nam, Juan Madoz-Gurpide, Hong Wang, David E. Misek, Samir M. Hanash
  • Patent number: 7319011
    Abstract: Follicular thyroid adenoma (FTA) is distinguished from follicular thyroid carcinoma (FTC) by comparing amount of an expression product of at least one gene selected from the group consisting of DDIT3, ARG2, ITM1, C1orf24, TARSH, and ACO1 in a test follicular thyroid specimen to a normal control thyroid specimen. The test follicular thyroid specimen is identified as FTA if the amount of expression product of TARSH is equal to or greater in the test follicular thyroid specimen than in the normal control thyroid specimen. The test follicular thyroid specimen is identified as FTC if the amount of expression product of DDIT3, ARG2, ITM1, C1orf24, or ACO1 is greater in the test follicular thyroid specimen than in the normal control thyroid specimen.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: January 15, 2008
    Assignee: Duke University
    Inventors: Gregory J. Riggins, Janete Cerruti
  • Patent number: 7319012
    Abstract: Methods of rapidly generating and analyzing a plurality of polypeptides are disclosed. More specifically, libraries and arrays of polypeptides are assayed in order to determine their individual immunogenic effect. Based on the immunogenic effect of polypeptides, specific subunit vaccines can be developed.
    Type: Grant
    Filed: May 29, 2002
    Date of Patent: January 15, 2008
    Assignee: Gene Therapy Systems, Inc.
    Inventors: Philip L. Felgner, Denise L. Doolan
  • Patent number: 7319013
    Abstract: The present invention relates to serine hydroxymethyltransferase (E.C. 2.1.2.1) as novel target for herbicides, and to nucleic acid sequences encoding a polypeptide with the biological activity of a serine hydroxymethyltransferase, which, when not present, bring about growth retardation symptoms and chlorotic leaves, comprising the nucleic acid sequence SEQ ID No:3, and functional equivalents of the abovementioned nucleic acid sequence or the nucleic acid sequence SEQ ID NO:7 and functional equivalents of the abovementioned nucleic acid sequence. Moreover, the present invention relates to the use of the abovementioned nucleic acid sequences, of functional analogs of the SEQ ID NO:3 or SEQ ID NO:7 or of polypeptides encoded by one of the abovementioned nucleic acid sequences in a method for identifying herbicidally active compounds which inhibit serine hydroxymethyltransferases, and to the use of these compounds which have been identified by the method as herbicides.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: January 15, 2008
    Assignee: BASF Aktiengesellschaft
    Inventors: Uwe Sonnewald, Frederik Börnke, Kirsten Deist, Marc Stitt Nigel, Wolfgang Lein, Thomas Ehrhardt, Andreas Reindl, Ralf-Michael Schmidt, Annette Freund
  • Patent number: 7319014
    Abstract: Compositions for an alkaline phosphatase and methods for over-expression and purification of thermolabile Antarctic phosphatase (TAP) are provided. Uses for TAP include dephosphorylation of nucleic acids, sugars, peptides and proteins. TAP as described herein has advantages over phosphatases from other sources with respect to thermolability at 65° C. and efficiency of dephosphorylation activity at approximately neutral pH.
    Type: Grant
    Filed: February 20, 2004
    Date of Patent: January 15, 2008
    Assignee: New England Biolabs, Inc.
    Inventors: Ellen Guthrie, Theodore Davis, Jack Benner, II
  • Patent number: 7319015
    Abstract: The present invention is directed to methods and compositions for improving pulmonary surfactant catabolism. More specifically, the specification describes methods and compositions for making and using a lysosomal phospholipase A2 in methods for the diagnosis, and treatment of disorders of phospholipid catabolism such as pulmonary alveolar proteinosis.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: January 15, 2008
    Assignee: The Regents of The University of Michigan
    Inventors: James A. Shayman, Akira Abe, Miki Hiraoka
  • Patent number: 7319016
    Abstract: Provided are crystals relating to Cathepsin S and its various uses.
    Type: Grant
    Filed: August 22, 2003
    Date of Patent: January 15, 2008
    Assignee: Takeda San Diego, Inc.
    Inventors: Ellen Chien, Douglas R. Dougan, Mark W. Knuth, Duncan E. McRee, Bi Ching Sang, Robert J. Skene, Ronald V. Swanson, Leslie W. Tari, Robert A. Wijnands
  • Patent number: 7319017
    Abstract: An in vitro method for identifying subjects at risk of heart failure following a Myocardial Infarction comprising analyzing the concentration of Matrix Metalloproteinase-9 in a bodily sample from a subject who has suffered a Myocardial Infarction and comparing this concentration with a reference for concentrations of Matrix Metalloproteinase-9 in individuals who have not suffered a Myocardial Infarction; wherein a raised concentration of Matrix Metalloproteinase-9 in the bodily sample from a subject who has suffered a Myocardial Infarction suggests the subject is at risk of heart failure.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: January 15, 2008
    Assignee: Centre de Recherche Public de la Santé
    Inventor: Daniel R. Wagner
  • Patent number: 7319018
    Abstract: We provide a lactate biosensing strip comprising a working electrode and a reference electrode, the two electrodes being deposited on an electrically insulated base support, the working electrode being formed by immobilizing lactate oxidase and an electron mediator on an inorganic graphite matrix and the graphite layer being deposited on a silver layer of the working electrode and the reference electrode being formed by depositing silver chloride on a silver layer of the reference electrode.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: January 15, 2008
    Assignee: Council of Scientific and Industrial Research
    Inventors: Manoj Kumar Pandey, Asha Chaubey, Krishan Kant Pande, Rajendra Kumar Sharma, Krishan Kumar Saini, Bansi Dhar Malhotra, Rajesh
  • Patent number: 7319019
    Abstract: Disclosed is the characterization and purification of DNA encoding a numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell) mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptides which may have use in stimulating glial cell mitogenesis and treating glial cell tumors. Methods for the synthesis, purification and testing of both known and novel polypeptides for their use as both therapeutic and diagnostic aids in the treatment of diseases involving glial cells are also provided. Also included is the mature GGF peptide and the DNA encoding said peptide, exclusive of the N-terminal signal sequence. The mature GGF peptide and DNA encoding the same are also useful for treatment of conditions of the central nervous system. Methods are also provided for the use of these polypeptides for the preparation of antibody probes useful for both diagnostic and therapeutic use in diseases involving glial cells.
    Type: Grant
    Filed: October 22, 1996
    Date of Patent: January 15, 2008
    Assignees: Acorda Therapeutics, Inc., Ludwig Institute for Cancer Research
    Inventors: Andrew David Goodearl, Paul Stroobant, Luisa Minghetti, Michael Waterfield, Mark Marchionni, Maio Su Chen, Ian Hiles
  • Patent number: 7319020
    Abstract: The invention relates to a method of obtaining a desired protein from a transgenic host organism, the gene coding for this protein being not expressed until the host organism has been harvested and the method being characterized in that (a) the transgenic host organism contains the gene coding for the desired protein such that it is only expressed in the presence of a chemical inductor, and (b) contacting with the inductor takes place via the phase surrounding the host organism after the host organism has been harvested. The invention also relates to a host organism suitable for carrying out this method.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: January 15, 2008
    Inventor: Klaus Düring
  • Patent number: 7319021
    Abstract: Cell lysis compositions, methods for extracting and isolating proteins and peptides from a host cells using the compositions, kits and apparatus for extracting and isolating protein and peptide molecules from host cells and for detecting for the presence of a protein or peptide. The composition allows for the extraction and isolation of proteins and peptides from host cells without the need for mechanical disruption and with or without isolation of the cells from cell medium. The composition includes at least one surfactant having a hydrophobic-lipophilic balance value in the range from about 11 to about 16; and at least one cell membrane altering compound.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: January 15, 2008
    Assignee: Promega Corporation
    Inventors: Laurie Engel, John W. Schultz, Tonny M. Johnson, Kristopher Zimmerman, Laura L. Bozek, Judith N. Stevens
  • Patent number: 7319022
    Abstract: Methods are provided for amplification and monitoring of oligonucleotide amplification in which a primer has an overlap with one or more bases of a detection probe.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: January 15, 2008
    Assignee: Epoch Biosciences, Inc.
    Inventors: Walt Mahoney, Nicolaas M. J. Vermeulen, Irina Afonina
  • Patent number: 7319023
    Abstract: An assay for detection of a mammalian cell proliferative disorder associated with a hypermutable nucleic acid sequences is provided. The identification of particular hypermutable sequences such as microsatellite loci correlates with a particular cancer, thereby allowing detection of both primary tumors and metastatic sites within a patient.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: January 15, 2008
    Assignee: The Johns Hopkins University
    Inventor: David Sidransky
  • Patent number: 7319024
    Abstract: The invention refers to a novel C. elegans p21-activated kinase gene, the pak-3 gene, and associated loss-of-function phenotypes. These phenotypes can be used to elucidate PAK signaling pathways in C. elegans and to screen compounds that modulate PAK signaling.
    Type: Grant
    Filed: January 28, 2005
    Date of Patent: January 15, 2008
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Kaj Grandien, Jonathan Rothblatt, Paola Concari, Isabelle Quelo, Bert Klebl
  • Patent number: 7319025
    Abstract: A method for producing L-glutamic acid by fermentation, which comprises culturing a microorganism having L-glutamic acid-producing ability in a liquid medium of which pH is adjusted to a condition under which L-glutamic acid produced by the microorganism is allowed to be precipitated, to allow L-glutamic acid to be produced and accumulated with precipitation of L-glutamic acid accompanied, wherein an operation causing existence of L-glutamic acid crystals in the medium is performed when a concentration of L-glutamic acid in the medium is lower than the concentration at which spontaneous crystallization occurs.
    Type: Grant
    Filed: January 9, 2003
    Date of Patent: January 15, 2008
    Assignee: Ajinomoto Co., Inc.
    Inventors: Hiroshi Ueda, Takayuki Koda, Masakazu Sato
  • Patent number: 7319026
    Abstract: The invention relates to amino acid-producing bacteria from the family Enterobacteriaceae, in particular from the species Escherichia coli, which contain a stop codon chosen from the group amber, ochre and opal in the nucleotide sequence for the coding region of the rpoS gene and a suppressor for a stop codon chosen from the group amber suppressor, ochre suppressor and opal suppressor. This invention also relates to a process for preparing amino acids, in particular L-threonine, using these bacteria.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: January 15, 2008
    Assignee: Degussa AG
    Inventors: Mechthild Rieping, Nicole Siebelt
  • Patent number: 7319027
    Abstract: Thermostable omega-transaminases, particularly thermostable omega-transaminases which have a high reaction rate and which are tolerant to high concentrations of donor amine, can be used to enrich enantiomerically a mixture of chiral amines or to synthesize stereoselectively one of a pair of chiral amines in which the amino group is bound to a non-terminal, chirally substituted, carbon atom.
    Type: Grant
    Filed: January 29, 2007
    Date of Patent: January 15, 2008
    Assignee: Cambrex Karlskoga AB
    Inventors: Sachin Pannuri, Sanjay Venkatesh Kamat, Abraham Rogelio Martin-Garcia
  • Patent number: 7319028
    Abstract: The present invention provides a process for efficiently producing sporangia of Bacillus popilliae containing spores and parasporal bodies having controlling effects on Scarabaeidae insects, and a control agent and controlling method for Scarabaeidae insects obtained by said production process. In a process for producing sporangia of Bacillus popilliae containing spores and parasporal bodies by culturing Bacillus popilliae in a medium containing an adsorbent, the medium contains 0.2-4.0% by weight of glutamic acid.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: January 15, 2008
    Assignees: Dainippon Ink and Chemicals, Inc., Chiba Prefectural Government
    Inventors: Gaku Ehara, Masaharu Kimura, Hideji Nishihashi, Tomoko Yokoyama, Makoto Hasegawa, Masao Tanaka, Azusa Fujiie, Shinichi Aoyagi
  • Patent number: 7319029
    Abstract: A biologically pure culture of Geobacillus Strain T1 bacteria isolated from Palm Oil Mill Effluent capable of producing thermostable lipase T1 gene. The production of thermostable lipase T1 gene from a novel Geobacillus bacterium having a designated as strain T1, was aerobic, gram positive and endospore-forming, rod-shaped. The G+C content of the genomic DNA was 52.6%. On the basic of physiological data, phenotypic traits and molecular analysis, strain T1 represents a novel species within the genus Geobacillus, The thermostable T1 lipase gene was subcloned into the pGEX-4T1 vector with and without signal peptide in prokaryotic system. The 28 amino acid residues signal peptide alter the conformation of GST moiety and preventing it from bind to affinity glutathione Sepharose column. By expression and simplification of the purification through single step affinity chromatography shows a specific activity of 292.929 U/mg and 72.55% of fusion lipase was recovered from crude cell lysate.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: January 15, 2008
    Assignee: Universiti Purta Malaysia
    Inventors: Raja Noor Zaliha Abd. Rahman, Abu Bakar Salleh, Mahiran Basri, Leow Thean Chor
  • Patent number: 7319030
    Abstract: A non-sporulating Bacillus subtilis strain, a method for preparing it and its use as a production organism. A method for preparing a biologically prepared product with the non-sporulating bacterium is also disclosed.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: January 15, 2008
    Assignee: Ipsat Therapies Oy
    Inventors: Pertti Koski, Susanna Kääriäinen
  • Patent number: 7319031
    Abstract: The invention is directed to a biological scanner for scanning biological growth plates. A biological growth plate can be loaded into the biological scanner. Upon loading of a biological growth plate, the biological scanner generates an image of the plate and may perform an analysis of the image. Various embodiments are directed to loading features that facilitate automated loading and proper positioning of a plate within the biological scanner, and ejection features that facilitate the automated ejection of the plate from the scanner. Additional embodiments are directed to features that allow a scanner unit of the biological scanner to be attached to a mounting platform of the scanner in different possible configurations.
    Type: Grant
    Filed: November 27, 2002
    Date of Patent: January 15, 2008
    Assignee: 3M Innovative Properties Company
    Inventors: Albert Vent, Klaus D. Kraetzig
  • Patent number: 7319032
    Abstract: The present invention provides methods, compositions, and kits for rapid detection of analytes in a sample. Surprisingly, it has been found that bulking materials having non-sugar sweeteners effectively enhance chromatographic detection methods by providing component stability and controlled release. Thus, the novel components and methods disclosed herein provide a completely new modality of chromatographic analyte detection.
    Type: Grant
    Filed: September 21, 2004
    Date of Patent: January 15, 2008
    Assignee: MedTox
    Inventors: Robert Bohannon, Glen Chapman, Alan Morris, Maria Scholz-Steele, Martin Green, Phillip Hartzog, Oluyomi Adeneye
  • Patent number: 7319033
    Abstract: Replication-competent adenovirus vectors specific for cells which allow a probasin transcriptional response element (PB-TRE) to function, such as cells which express the androgen receptor (AR), and methods of use of such viruses are provided. These viruses comprise an adenoviral gene under control of a transcriptional regulatory portion of a PB-TRE, which is in turn dependent upon AR expression. The gene can be, for example, a gene required for viral replication or the adenovirus death protein gene (ADP). The viruses can also comprise at least one additional adenoviral gene under control of at least one additional prostate-specific transcriptional response element, such as that controlling prostate-specific antigen expression (PSA-TRE). Thus, virus replication can be restricted to target cells exhibiting prostate-specific gene expression, particularly prostate carcinoma cells.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: January 15, 2008
    Assignee: Cell Genesys, Inc.
    Inventors: Daniel R. Henderson, Eric R. Schuur, De-Chao Yu
  • Patent number: 7319034
    Abstract: Phosphorylated Apoptin is described. Apoptin is tumor-specifically phosphorylated and part of the Apoptin apoptotic pathway in tumor cells is elucidated. New therapeutic possibilities, for example, novel therapeutic compounds that can work alone or, sequentially to, or jointly with other known compounds. Also, the use of tumor-specifically phosphorylation of Apoptin for diagnostic purposes is described. Such a diagnostic purpose can, for example, be a method for detecting the presence of cancer cells or cells that are cancer prone or a method to identify a putative cancer inducing agent or a method for the in vitro treatment effect of Apoptin on tumor cells by testing the phosphorylation state of Apoptin. Even more, the invention provides possibilities to further elucidate the apoptotic pathway and to identify for example crucial mediators of phosphorylation in human tumor cells. Interfering with such a mediator could provide new anti-cancer therapies.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: January 15, 2008
    Assignee: Leadd B.V.
    Inventors: Mathieu Hubertus Maria Noteborn, Jennifer Leigh Rohn, Dominik Mumberg, Peter Donner
  • Patent number: 7319035
    Abstract: The invention provides methods of generating a natural, living biological matrix that can serve as, or form a part of, a natural biological scaffold. The matrix is generated by incubating together biological cells and cellular debris. Any naturally occurring cell can be a biological cell included in the matrix. The invention also provides methods of treating a patient by implanting the matrix or scaffolding into a tissue of the patient, thereby augmenting the existing tissue.
    Type: Grant
    Filed: October 17, 2003
    Date of Patent: January 15, 2008
    Assignee: VBI Technologies, L.L.C.
    Inventors: Martin P. Vacanti, Charles A. Vacanti
  • Patent number: 7319036
    Abstract: Dominant negative alleles of human mismatch repair genes can be used to generate hypermutable cells and organisms. By introducing these genes into cells and transgenic animals, new cell lines and animal varieties with novel and useful properties can be prepared more efficiently than by relying on the natural rate of mutation. The enhanced rate of mutation can be further augmented using mutagens. Moreover, the hypermutability of mismatch repair deficient cells can be remedied to stabilize cells or mammals with useful mutations.
    Type: Grant
    Filed: June 23, 2004
    Date of Patent: January 15, 2008
    Assignees: The Johns Hopkins University School of Medicine, Morphotek, Inc.
    Inventors: Nicholas C. Nicolaides, Philip M. Sass, Luigi Grasso, Bert Vogelstein, Kenneth W. Kinzler
  • Patent number: 7319037
    Abstract: Fluid testing device for determining the value of each of a plurality of properties of a fluid, the fluid testing device including a planar base and a plurality of test sections, located on the planar base, each of the test sections including a test sub-section which exhibits a color according to the value, as a result of reaction of a reagent with the fluid and a reference section located adjacent to the test sub-section, the reference section including a plurality of different reference colors.
    Type: Grant
    Filed: May 14, 2002
    Date of Patent: January 15, 2008
    Inventor: Orit Albeck-Marom
  • Patent number: 7319038
    Abstract: A food spoilage sensor of the general formula wherein M is a transition metal ion; D1, D2, D3 and D4 can be the same or different and can be N or P; R1 and R2, R3 and R4, R5 and R6, and R7 and R8 can be the same or different and from, taken together with the adjacent carbon atoms to which they are bonded and joined together, an aromatic or a cyclic group with at least one of the aromatic or cyclic groups possessing one or more polymerizable moieties. The complex selectively binds biogenic amines which are released by food spoilage microorganisms and undergo a detectable color change upon exposure thereto.
    Type: Grant
    Filed: September 17, 2003
    Date of Patent: January 15, 2008
    Assignee: The Johns Hopkins University
    Inventor: Glen E. Southard
  • Patent number: 7319039
    Abstract: The presence of an aerosol or cloud (3) of a toxic substance is detected by producing an aerosol (17, 5) of ligands (13) to the target substance in a region of sky that contains the target substance, permitting molecules the target substance to bind to the ligand, directing light (7, 21) of a first frequency into the revised aerosol; and then inspecting (9, 25) the revised aerosol for emissions of light of a second frequency. When light of the second frequency exists an alarm (15, 31) is initiated.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: January 15, 2008
    Assignee: Northrop Grumman Corporation
    Inventor: Brian M. Sullivan
  • Patent number: 7319040
    Abstract: A method for providing improved estimates of properties of a chemical manufacturing process is disclosed. The method employs a process model that includes, or is modified by, scores or other gains obtained from the mathematical transformation of data obtained from an on-line analyzer. Chemical manufacturing processes using the method also are disclosed.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: January 15, 2008
    Assignee: Ineos USA LLC
    Inventors: Ramaswamy Vaidyanathan, Ronald S. Hurlbut, William D. Stephens, David R. Van Hare
  • Patent number: 7319041
    Abstract: Chemiluminescent acridinium compounds are used in homogeneous assays to determine the concentration of an analyte in a sample without strong acid or strong base treatment. The chemiluminescent acridinium compounds include acridinium esters with electron donating functional groups at the C2 and/or C7 position on the acridinium nucleus to inhibit pseudo-base formation, or acridinium sulfonamides with or without electron donating functional groups at the C2 and/or C7 position on the acridinium nucleus.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: January 15, 2008
    Assignee: Siemens Medical Solutions Diagnostic
    Inventors: Anand Natrajan, Todd Sells, Hartmut Schroeder, Guohan Yang, David Sharpe, Qingping Jiang, Hana Lukinsky, Say-Jong Law
  • Patent number: 7319042
    Abstract: A semiconductor device is manufactured in such a way that a semiconductor chip connected with leads whose internal ends are interconnected with bonding wires are completely sealed and enclosed in a resin corresponding to a package while external ends of leads are exposed from the surface of the package. In manufacture, a chip fixing member is used to fix the semiconductor chip in a prescribed position, while wire fixing members are used to fix the bonding wires in prescribed positions. Both the fixing members are retracted into the split mold so as to avoid formation of unfilled portions or voids in the resin in the cavity. In inspection, an electrical conduction is detected between the bonding wire(s) and an electrode layer formed inside of the cavity, so that a semiconductor device produced in the cavity is automatically removed from the manufacturing line.
    Type: Grant
    Filed: December 6, 2002
    Date of Patent: January 15, 2008
    Assignee: Yamaha Corporation
    Inventor: Kenichi Shirasaka
  • Patent number: 7319043
    Abstract: The present invention provides an efficient test method and system for testing the IC package, such as BGA types of packages. With the present invention, manufacturer can have an easier way in testing various types of packages, including newer types. Manufacturer also can get the testing outcome which is more accurate. Furthermore, the present invention helps the manufacturer achieve a significant improvement in an IC packaging process.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: January 15, 2008
    Assignee: Advanced Chip Engineering Technology Inc.
    Inventors: Wen-Kun Yang, Cheng Chieh Tai
  • Patent number: 7319044
    Abstract: A nitride semiconductor light emitting device includes a substrate, an n-type nitride semiconductor layer formed on the substrate and provided with an electrode region of a predetermined area adjacent to a center of one lateral side of the top surface of the substrate, an n-type electrode formed on the electrode region, an activation layer, a p-type nitride semiconductor layer, and a p-type electrode which has a bonding pad adjacent to a center of another lateral side opposite to the lateral side adjacent to the electrode region to have a predetermined space from the n-type electrode and a band-shaped extension connected to the bonding pad to extend along a lateral side of the top surface of the p-type nitride semiconductor layer in opposite directions from a connected portion of the extension with the bonding pad.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: January 15, 2008
    Assignee: Samsung Electro-Mechanics Co., Ltd.
    Inventors: Young Suk Han, Sung Wook Kim, Suk Kil Yoon
  • Patent number: 7319045
    Abstract: A method for fabricating GaN-based LED is provided. The method first forms a first contact spreading metallic layer on top of the texturing surface of the p-type ohmic contact layer. The method then forms a second and a third contact spreading metallic layers on top of the first contact spreading layer. The p-type transparent metallic conductive layer composed of the three contact spreading metallic layers, after undergoing an alloying process within an oxygenic or nitrogenous environment under a high temperature, would have a superior conductivity. The p-type transparent metallic conductive layer could enhance the lateral contact uniformity between the p-type metallic electrode and the p-type ohmic contact layer, so as to avoid the localized light emission resulted from the uneven distribution of the second contact spreading metallic layer within the third contact spreading metallic layer. The GaN-based LED's working voltage and external quantum efficiency are also significantly improved.
    Type: Grant
    Filed: July 3, 2006
    Date of Patent: January 15, 2008
    Assignee: Super Nova Optoelectronics Corporation
    Inventors: Mu-Jen Lai, Schang-Jing Hon
  • Patent number: 7319046
    Abstract: An integrated optoelectronic silicon biosensor that can detect biomolecules by the change of the optical coupling between the integrated light source and the integrated detector that is caused by the binding of the appropriately labeled analytes onto the recognition molecules, that have been previously immobilized onto the integrated optical fiber that connects the optical source with the detector. The device contains the optoelectronic silicon chip and its biological activation. The optoelectronic chip is realized following integrated circuits fabrication methods so as the light source, the detector and the optical fiber, that optically couples the light source with the detector, to be monolithically integrated on the same silicon substrate. The biological activation of the chip is performed through physicochemical modification of the chip surface in order to permit immobilization of the recognition biomolecules onto the optical fiber surface.
    Type: Grant
    Filed: November 29, 2002
    Date of Patent: January 15, 2008
    Assignees: National Centre for Scientific Research Demkritos
    Inventors: Konstantinos Misiakos, Sotirios Kakabakos
  • Patent number: 7319047
    Abstract: A polymer well may be formed over a thermal oxide formed over a semiconductor substrate in one embodiment. The well may include a waveguide and a pair of heaters adjacent the waveguide. Each heater may be mounted on a platform of insulating material to reduce heat loss through the substrate and the thermal oxide, in one embodiment.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: January 15, 2008
    Assignee: Intel Corporation
    Inventors: Ruolin Li, Ut Tran
  • Patent number: 7319048
    Abstract: Embodiments relate to electronic assemblies and methods for forming electronic assemblies. One method includes providing a die and a copper heat spreader that are to be coupled to one another through a thermal interface material. A layer of tin is formed on the copper heat spreader. The heat spreader and the die are clamped together with the tin positioned between the heat spreader and the die. The assembly is heated so that the tin melts and forms at least one intermetallic compound with copper from the heat spreader. The heat spreader is then coupled to the die through the intermetallic compound.
    Type: Grant
    Filed: September 3, 2004
    Date of Patent: January 15, 2008
    Assignee: Intel Corporation
    Inventors: Daoqiang Lu, Chuan Hu
  • Patent number: 7319049
    Abstract: A method of manufacturing an electronic parts packaging structure of the present invention, includes the steps of forming a first uncured resin layer on a substrate, arranging an electronic parts on the first uncured resin layer, forming a second uncured resin layer that covers the electronic parts, and obtaining an insulating layer, in which the electronic parts is embedded, by curing the first uncured resin layer and the second uncured resin layer by annealing.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: January 15, 2008
    Assignee: Shinko Electric Industries Co., Ltd.
    Inventors: Kiyoshi Oi, Yasuyoshi Horikawa, Akihito Takano
  • Patent number: 7319050
    Abstract: A wafer level chip scale packaging structure and the method of fabricating the same are disclosed to form a sacrificial layer below the bump using a normal semiconductor process. The bump is used to connect the signals between the Si wafer and the PCB. The interface between the sacrificial layer and the PCB is the weakest part in the whole structure. When the stress applied to the bump is overloaded, the interface between the sacrificial layer and the adjacent layers will peel or the sacrificial layer material will crash to remove the stress generated by different thermal expansion coefficients of the Si wafer and the PCB. The sacrificial layer would help avoid the crash occurring to the bump to protect the electrical conduction between the Si wafer and the PCB.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: January 15, 2008
    Assignee: Industrial Technology Research Institute
    Inventors: Shu-Ming Chang, Lee-Cheng Shen
  • Patent number: 7319051
    Abstract: A thermally enhanced wirebond BGA package having a laminate substrate, an IC device mounted on the substrate, and a metal cap defining a cavity inside the package between the IC device and the metal cap. A substantial portion of the cavity is filled with a thermally enhanced epoxy encapsulant establishing a thermal conduction path between the IC device and the metal cap. The BGA package may be further enhanced by bonding a metal heat slug on the laminate substrate and mounting the IC device on the slug.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: January 15, 2008
    Assignee: Altera Corporation
    Inventors: Eng C. Cheah, Donald S. Fritz
  • Patent number: 7319052
    Abstract: An alloying method includes the steps of forming a metal layer on a semiconductor having been transferred to a material having a low thermal conductivity, and alloying an interface between the semiconductor and the metal layer by irradiating the interface with a laser beam having a wavelength absorbable in at least one of the semiconductor and the metal layer. The irradiation energy of the laser beam is set in a range of 20 to 100 mJ/cm2. The material having a low thermal conductivity is a resin or amorphous silicon. According to the alloying method using laser irradiation, since the entire semiconductor is not heated and only a necessary portion is locally heated, the necessary portion can be readily alloyed to be converted into an ohmic contact without exerting adverse effect on characteristics of the semiconductor device.
    Type: Grant
    Filed: April 11, 2005
    Date of Patent: January 15, 2008
    Assignee: Sony Corporation
    Inventors: Katsuhiro Tomoda, Toyoharu Ohata
  • Patent number: 7319053
    Abstract: A very high density field programmable memory is disclosed. An array is formed vertically above a substrate using several layers, each layer of which includes vertically fabricated memory cells. The cell in an N level array may be formed with N+1 masking steps plus masking steps needed for contacts. Maximum use of self alignment techniques minimizes photolithographic limitations. In one embodiment the peripheral circuits are formed in a silicon substrate and an N level array is fabricated above the substrate.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: January 15, 2008
    Assignee: SanDisk 3D LLC
    Inventors: Vivek Subramanian, James M. Cleeves
  • Patent number: 7319054
    Abstract: A liquid crystal display device and a method of fabricating the same are disclosed in the present invention. The liquid crystal display device includes a gate line and a data line crossing each other on a substrate, a pixel electrode at an area defined by the gate line and the data line, a gate electrode connected to the gate line, a source electrode connected to the data line, a drain electrode connected to the pixel electrode, and a semiconductor layer acting as a channel between the source and drain electrode, wherein the data line and the semiconductor layer has a trench formed at a side facing to the drain electrode.
    Type: Grant
    Filed: August 15, 2005
    Date of Patent: January 15, 2008
    Assignee: LG.Philips LCD Co., Ltd.
    Inventor: Hyong Wook Jang
  • Patent number: 7319055
    Abstract: To provide a method of efficiently configuring a circuit requiring high inter-device consistency by using thin-film transistors. A semiconductor layer is formed on a substrate and is patterned into desired shapes to form first semiconductor islands. The first semiconductor islands are uniformly crystallized by laser irradiation within the surface areas thereof. Thereafter, the semiconductor layers are patterned into desired shapes to become active layers of the thin-film transistors layer. Active layers of all of thin-film transistors constituting one unitary circuit are formed of one of the first semiconductor islands in this case. Thus, the TFTs mutually realize high consistency.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: January 15, 2008
    Assignee: Semiconductor Energy Laboratory Co., Ltd.
    Inventors: Chiho Kokubo, Aiko Shiga, Yoshifumi Tanada, Shunpei Yamazaki
  • Patent number: 7319056
    Abstract: Methods for processing an amorphous silicon thin film sample into a polycrystalline silicon thin film are disclosed.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: January 15, 2008
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: James S. Im, Robert S. Sposili, Mark A. Crowder
  • Patent number: 7319057
    Abstract: A lower electrode may be covered by a protective film to reduce the exposure of the lower electrode to subsequent processing steps or the open environment. As a result, materials that may have advantageous properties as lower electrodes may be utilized despite the fact that they may be sensitive to subsequent processing steps or the open environment.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: January 15, 2008
    Assignee: Ovonyx, Inc.
    Inventor: Tyler A. Lowrey
  • Patent number: 7319058
    Abstract: A fabrication method for a non-volatile memory is provided. To fabricate the non-volatile memory, a plurality of first trenches and second trenches are formed in a substrate, wherein the second trenches are disposed above the first trenches and cross over the first trenches. Then, a tunneling layer and a charge storage layer are sequentially formed on both sidewalls of each second trench. An isolation layer is filled into the first trench. Furthermore, a charge barrier layer is formed on the sidewall of the second trench, and a gate dielectric layer is formed at the bottom of the second trench. A control gate layer is filled into the second trench. Finally, two first doping regions are formed in the substrate at both sides of the control gate layer.
    Type: Grant
    Filed: August 15, 2005
    Date of Patent: January 15, 2008
    Assignee: ProMOS Technologies Inc.
    Inventor: Ting-Sing Wang